Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Lymphoma 13Multiple Myeloma 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 7Leukemia, Myeloid, Acute 7Leukemia 7Breast Neoplasms 7Neuroblastoma 6Neoplasms, Plasma Cell 6Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Burkitt Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Testicular Neoplasms 3Testicular Germ Cell Tumor 3Prostatic Neoplasms 3Myelodysplastic Syndromes 3Lymphoma, B-Cell, Marginal Zone 3Lung Neoplasms 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Central Nervous System Neoplasms 3Waldenstrom Macroglobulinemia 2Seminoma 2Ovarian Neoplasms 2

Interventions

Cisplatin 12Radiotherapy 6Gemcitabine 6Paclitaxel 5Fluorouracil 4Radiotherapy, Intensity-Modulated 3Docetaxel 3spartalizumab 2sintilimab 2nimotuzumab 2camrelizumab 2Surveys and Questionnaires 2Endostatins 2Carboplatin 2triethanolamine 1toripalimab 1regramostim 1fluzoparib 1fluoromisonidazole 1endostar protein 1Vitamin B 12 1Tomography, Optical Coherence 1Taxes 1Rubidium-82 1Ritonavir 1Re-Irradiation 1Procaine 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Nasopharyngeal Neoplasms × Filgrastim × Clear all
NCT00004164 2009-02-09

Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx

National Cancer Institute (NCI)

Phase 2 Unknown
Head & Neck

Head and Neck Neoplasms, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡